For: | Juneja D, Nasa P, Jain R, Singh O. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports. World J Diabetes 2023; 14(8): 1314-1322 [PMID: 37664476 DOI: 10.4239/wjd.v14.i8.1314] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i8/1314.htm |
Number | Citing Articles |
1 |
Alessandro Rossi, Chiara Simeoli, Rosario Pivonello, Mariacarolina Salerno, Carmen Rosano, Barbara Brunetti, Pietro Strisciuglio, Annamaria Colao, Giancarlo Parenti, Daniela Melis, Terry G.J. Derks. Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care. Reviews in Endocrine and Metabolic Disorders 2024; 25(4): 707 doi: 10.1007/s11154-024-09880-2
|
2 |
Swapnil Khare, Mihail Zilbermint, Rajesh Garg, Viral N. Shah. Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report. Endocrine Practice 2024; 30(9): 895 doi: 10.1016/j.eprac.2024.06.011
|
3 |
Dimitra Stathi, Ketan K. Dhatariya, Omar G. Mustafa. Management of diabetes‐related hyperglycaemic emergencies in advanced chronic kidney disease: Review of the literature and recommendations. Diabetic Medicine 2024; doi: 10.1111/dme.15405
|
4 |
Andrijana Koceva, Nika Aleksandra Kravos Tramšek. From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Journal of Personalized Medicine 2024; 14(7): 665 doi: 10.3390/jpm14070665
|
5 |
Rohini Garg, Nikhil Sood, Ojas Bansal, Abhinav Hoskote. Euglycemic Ketoacidosis Associated with SGLT-2 Inhibitors in Non-diabetic Patients—A Narrative Review. Journal of General Internal Medicine 2024; doi: 10.1007/s11606-024-09073-2
|
6 |
Afif Nakhleh, Areen Othman, Amin Masri, Moshe Zloczower, Sagit Zolotov, Naim Shehadeh. Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. Biomedicines 2023; 11(10): 2689 doi: 10.3390/biomedicines11102689
|